SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-074048
Filing Date
2019-12-19
Accepted
2019-12-19 07:00:42
Documents
12
Period of Report
2019-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1926562d1_8k.htm   iXBRL 8-K 38362
  Complete submission text file 0001104659-19-074048.txt   215956

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA egrx-20191213.xsd EX-101.SCH 3183
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20191213_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20191213_pre.xml EX-101.PRE 22708
6 EXTRACTED XBRL INSTANCE DOCUMENT tm1926562d1_8k_htm.xml XML 3619
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 191294119
SIC: 2834 Pharmaceutical Preparations